Stockreport

How Recent Developments Are Shaping the Hikma Pharmaceuticals Story and Its Valuation [Yahoo! Finance]

HIKMA PHARMS PLC S/ADR  (HKMPY) 
NASDAQ:AMEX Investor Relations: hikma.com/en/investors.html
PDF Hikma Pharmaceuticals' consensus analyst price target has seen a slight dip, moving from £23.55 to £23.36 per share. This adjustment comes as recent research indicates t [Read more]